Dopamine Hydrochloride Injection Shortage
Last Updated: September 3, 2025
Status: Current
Unavailable, Current:
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (Hospira, Inc., a Pfizer Company)
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (Hospira, Inc., a Pfizer Company)
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (Hospira, Inc., a Pfizer Company)
- Dopamine Hydrochloride, Injection, 40 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
Available, Current:
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (Baxter Healthcare)
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (Baxter Healthcare)
- Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (Hospira, Inc., a Pfizer Company)
- Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (Hospira, Inc., a Pfizer Company)
To Be Discontinued:
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-7809-22Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Next Delivery: October 2025; Estimated Recovery: December 2025
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-7810-22Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Next Delivery: October 2025; Estimated Recovery: December 2025
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-7809-24Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Shortage per Manufacturer: Manufacturing Delay
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dopamine Hydrochloride, Injection, 40 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
NDC Code: 0143-9252-25Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Additional lots will be available in the October 2025 timeframe. Product will be made available as it is released.
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 800-631-2174
Dopamine Hydrochloride, Injection, 40 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
NDC Code: 0143-9254-25Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Additional lots will be available in the October 2025 timeframe. Product will be made available as it is released.
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 800-631-2174
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (Baxter Healthcare)
NDC Code: 0338-1007-02Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 888-229-0001
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (Baxter Healthcare)
NDC Code: 0338-1007-03Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 888-229-0001
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (Baxter Healthcare)
NDC Code: 0338-1005-03Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 888-229-0001
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (Baxter Healthcare)
NDC Code: 0338-1005-02Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 888-229-0001
Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-5820-01Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Revised
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-9104-20Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Revised
Therapeutic category: Cardiovascular
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dopamine Hydrochloride in Dextrose 5% in plastic container, Injection, 800 mg/500 mL (1,600 mcg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-7809-24Status: To Be Discontinued
Date of update: August 27, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Cardiovascular
Initial posting date: August 27, 2025
Contact info: 844-646-4398
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.